ZAGENO Secures $33M in Funding to Revolutionize Life Sciences Research Procurement
ZAGENO empowers life science research with unparalleled efficiency and cost savings
CAMBRIDGE, Mass., May 25, 2023 (Newswire.com) — ZAGENO, the leading online marketplace for life science research products, announces the closing of a $33 million funding round. General Catalyst, the largest public pension fund in the United States, Grazia Equity, OakRidge Management Group and a German investment firm led the round, joined by existing investors Capnamic Ventures and HighSage Ventures.
This funding propels ZAGENO’s expansion in the United States and Europe, dramatically improving the accessibility and affordability of life science research products. ZAGENO simplifies product discovery, experience planning, and seamless purchasing from thousands of vendors. The marketplace revolutionizes scientific workflow, saving time and product costs. With a wide selection of quality products and verified vendors, scientists benefit from competitive pricing aided by market transparency and vendor choice.
“We are delighted to welcome new investors, including one of America’s most powerful shareholders and the global leader in the investment industry and a leading German investment firm, while benefiting from the continued support from General Catalyst and existing investors,” said Florian Wegener, CEO of ZAGENO. “This funding allows scientists to focus on creating scientific value.”
ZAGENO’s online marketplace offers a wide selection of products and services, including laboratory equipment, consumables, chemicals, antibodies and custom solutions. By giving scientists access to a network of verified suppliers, the ZAGENO platform enables informed purchasing decisions.
“ZAGENO is transforming the scientific research industry with its revolutionary platform,” said Larry Bohn, managing partner at General Catalyst. “We proudly support their journey.”
“With this funding, ZAGENO is able to deliver even greater value to scientists around the world,” said Joe von Rickenbach, Chairman of ZAGENO’s Board of Directors. “Their innovative platform generates unparalleled efficiency and cost savings.”
ZAGENO is poised for rapid growth and pioneering innovation in the scientific research industry with this new funding.
To learn more about ZAGENO, visit www.zageno.com.
ZAGENO is a marketplace for life science research products. By revolutionizing the way scientists discover, purchase and manage life science research products, ZAGENO supports researchers who pursue breakthroughs that improve our lives. With a comprehensive catalog, advanced search functionality, transparent pricing, and dedicated customer support, ZAGENO simplifies the research workflow and frees scientists to focus on breakthrough discoveries. ZAGENO is a global company with offices in Cambridge, San Francisco, Berlin and Bangalore. For more information, visit www.zageno.com.
About General Catalyst
General Catalyst is a venture capital firm that invests in powerful, positive change that lasts – for our entrepreneurs, investors, employees, and society. We support founders with a long-term vision that challenges the status quo, partnering with them from seed to growth and beyond to build companies that stand the test of time. With offices in San Francisco, Palo Alto, New York, London and Boston, the company has helped support the growth of companies such as: Airbnb, Deliveroo, Guild, Gusto, Hubspot, Illumio, Lemonade, Livongo, Oscar, Samsara , Snap, Stripe and Warby Parker. For more information: www.generalcatalyst.com.